Trial Profile

An Exploratory, Open Label, Randomized, Parallel Group Study To Investigate The Pharmacokinetics Of Single Intravenous And Oral Micro Doses Of PF-05186462, PF-05089771, PF-05241328 And PF-05150122 In Healthy Male Subjects

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 23 Feb 2016

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs PF 5089771 (Primary) ; PF 5089771 (Primary) ; PF 5141328 (Primary) ; PF 5141328 (Primary) ; PF 5150122 (Primary) ; PF 5150122 (Primary) ; PF 5186462 (Primary) ; PF 5186462 (Primary)
Indications Pain
Focus Adverse reactions; Pharmacokinetics
Sponsors Pfizer

19 Feb 2016 Results of two phase I studies published in the Clinical Pharmacokinetics.
23 Aug 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
10 Aug 2010 Actual initiation date added to 1 Jul 2010 as reported by ClinicalTrials.gov.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com